July 2018—Cancer Genetics announced it has received special 510(k) clearance from the FDA for its Tissue of Origin test following modifications made to test reagents and software.
Read More »/chroot/home/a0eace02/dev.captodayonline.com/html/wordpress/wp-content/themes/jarida
July 2018—Cancer Genetics announced it has received special 510(k) clearance from the FDA for its Tissue of Origin test following modifications made to test reagents and software.
Read More »